Cariad Chester

Cariad Chester currently serves as the Managing Partner at TCGX since 2021. Prior to this role, Cariad was the Managing Director at Aquilo Capital from 2015 to 2021. Additionally, Cariad contributed to immunotherapy research at Stanford University School of Medicine between 2013 and 2017. Cariad Chester holds a double major in Neuroscience and Comparative Religious Studies from Swarthmore College.